Abstract
The steady-state levels of p53 mRNA were dramatically lower in immortal chicken embryo fibroblast (CEF) cell lines compared to primary CEF cells. In the presence of cycloheximide (CHX), the steady-state levels of p53 mRNA markedly increased in immortal CEF cell lines, similar to levels found in primary cells. The de novo synthetic rates of p53 mRNA were relatively similar in primary and immortal cells grown in the presence or absence of CHX. Destabilization of p53 mRNA was observed in the nuclei of immortal, but not primary, CEF cells. The half-life of p53 mRNA in primary cells was found to be a relatively long 23 h compared to only 3 h in immortal cells. The expression of transfected p53 cDNA was inhibited in immortal cells, but restored upon CHX treatment. The 5′-region of the p53 mRNA was shown to be involved in the rapid p53 mRNA destabilization in immortal cells by expression analysis of 5′- and 3′-deleted p53 cDNAs as well as fusion mRNA constructs of N-terminal p53 and N-terminal deleted LacZ genes. Together, it is suggestive that the downregulation of p53 mRNA in immortal CEF cells occurs through a post-transcriptional destabilizing mechanism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- HPV:
-
human papillomavirus
- SV40:
-
simian virus 40
- CEF:
-
chicken embryonic fibroblast
- RT–PCR:
-
reverse transcriptase-PCR
- ActD:
-
actinomycin D
- ev-0:
-
endogenous virus-free
- SPAFAS:
-
specific pathogen free avian supply
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- CHX:
-
cycloheximide
- CMV:
-
cytomegalovirus
References
Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T . 2000 Genes Dev. 14: 704–718
Chen CY, Shyu AB . 1995 Trends Biochem. Sci. 20: 465–470
D'Erchia AM, Pesole G, Tullo A, Saccone C, Sbisà E . 1999 Genomics 58: 50–64
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983
Grosset C, Chen CY, Xu N, Sonenberg N, Jacquemin-Sablon H, Shyu AB . 2000 Cell 103: 29–40
Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299
Herrick DJ, Ross J . 1994 Mol. Cell. Biol. 14: 2119–2128
Honda R, Yasuda H . 1999 EMBO J. 18: 22–27
Jiang D, Srinivasan A, Lozano G, Robbins RD . 1993 Oncogene 8: 2805–2812
Kim H, You S, Kim I-J, Farris J, Foster LK, Foster DN . 2001a Exp. Cell Res. 265: 339–347
Kim H, You S, Kim I-J, Foster LK, Farris J, Ambady S, Ponce de León FA, Foster DN . 2001b Oncogene 20: 2671–2682
Kim H, You S, Farris J, Foster LK, Foster DN . 2001c Oncogene 20: 3306–3310
Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072
Kubbutat MHG, Jones SN, Vousden KH . 1997 Nature 387: 299–303
Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D . 1994 Br. J. Cancer 69: 409–419
Madisen L, Krumm A, Hebbes TR, Groudine M . 1998 Mol. Cell. Biol. 18: 6281–6292
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W . 1995 EMBO J. 14: 4442–4449
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N . 2000 Science 288: 1053–1058
Ross J . 1995 Microbiol. Rev. 59: 423–450
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . 1990 Cell 63: 1129–1136
Shyu AB, Greenberg ME, Belasco JG . 1989 Genes Dev. 3: 60–72
Soussi T, May P . 1996 J. Mol. Biol. 260: 623–637
Tao W, Levine AJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6937–6941
Yeilding NM, Procopio WN, Rehman MT, Lee WMF . 1998 J. Biol. Chem. 273: 15749–15757
Acknowledgements
This work was supported, in part, by USDA/NRICGP grant #9603280 and a grant from American Home Products (Fort Dodge Animal Health) to DN Foster.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, H., You, S., Foster, L. et al. The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells. Oncogene 20, 5118–5123 (2001). https://doi.org/10.1038/sj.onc.1204664
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204664
Keywords
This article is cited by
-
p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements
Journal of Molecular Medicine (2020)
-
Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells
Tumor Biology (2015)
-
Regulation of tumor suppressor p53 at the RNA level
Journal of Molecular Medicine (2010)
-
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner
Cancer Chemotherapy and Pharmacology (2007)
-
Contributions of differential p53 expression in the spontaneous immortalization of a chicken embryo fibroblast cell line
BMC Cell Biology (2006)